H R Arnstein
Overview
Explore the profile of H R Arnstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Wiseman H, Cannon M, Arnstein H, Halliwell B
Biochim Biophys Acta
. 1993 Jun;
1181(3):201-6.
PMID: 8318548
The anticancer drug tamoxifen inhibits lipid peroxidation in ox-brain phospholipid liposomes, and is a good antiyeast agent, with clinical potential. We now report that the ergosterol-containing lipid fraction derived from...
3.
Wiseman H, Cannon M, Arnstein H, Halliwell B
Biochem Pharmacol
. 1993 May;
45(9):1851-5.
PMID: 8494544
Tamoxifen and 4-hydroxytamoxifen were both good inhibitors of iron-dependent lipid peroxidation in rat cardiac microsomes. Tamoxifen was also a good inhibitor of lipid peroxidation in liposomes prepared from the phospholipid...
4.
Wiseman H, Smith C, Halliwell B, Cannon M, Arnstein H, Lennard M
Cancer Lett
. 1992 Sep;
66(1):61-8.
PMID: 1451097
Droloxifene (3-hydroxytamoxifen), is a triphenylethylene derivative recently developed for the treatment of breast cancer. Droloxifene was found to exhibit a membrane antioxidant ability in that it inhibited Fe(III)-ascorbate dependent lipid...
5.
Wiseman H, Cannon M, Arnstein H, Barlow D
Biochim Biophys Acta
. 1992 Mar;
1138(3):197-202.
PMID: 1547281
The anti-cancer drug tamoxifen is a potent inhibitor of lipid peroxidation induced by Fe(III)-ascorbate in ox-brain phospholipid liposomes. Similar anti-oxidant effects, but with varying potencies, are also shown by 4-hydroxy-tamoxifen,...
6.
The antioxidant action of ketoconazole and related azoles: comparison with tamoxifen and cholesterol
Wiseman H, Smith C, Arnstein H, Halliwell B, Cannon M
Chem Biol Interact
. 1991 Jan;
79(2):229-43.
PMID: 1884432
The azole antifungal drug ketoconazole was found to inhibit Fe(III)-ascorbate dependent lipid peroxidation using either rat liver microsomes or ox-brain phospholipid liposomes as the substrate. It also inhibited microsomal peroxidation...
7.
Wiseman H, Cannon M, Arnstein H
Biochem Soc Trans
. 1990 Dec;
18(6):1167-8.
PMID: 2088838
No abstract available.
8.
Wiseman H, Cannon M, Arnstein H, Halliwell B
FEBS Lett
. 1990 Nov;
274(1-2):107-10.
PMID: 2253763
The anticancer drug tamoxifen when introduced into phospholipid liposomes during their preparation inhibited Fe(III)-ascorbate induced lipid peroxidation to a greater extent than similarly introduced cholesterol. Ergosterol was equipotent with tamoxifen,...
9.
Wiseman H, Cannon M, Arnstein H
Biochem Soc Trans
. 1990 Oct;
18(5):877-8.
PMID: 2083708
No abstract available.
10.
Wiseman H, Cannon M, Arnstein H
Biochem Soc Trans
. 1990 Aug;
18(4):557-8.
PMID: 2276433
No abstract available.